Skip to main content
Premium Trial:

Request an Annual Quote

GATC Biotech Installs Second HiSeq 2000 for Large-Scale Projects


This story was originally published July 8

German sequencing service provider GATC Biotech said last week that it will install a second Illumina HiSeq 2000 instrument, which will go into production later this month.

The company purchased its first HiSeq 2000 earlier this year (IS 1/26/2010). Both instruments will be used to sequence pediatric brain tumors for a project that is part of the International Cancer Genome Consortium (IS 5/25/2010), as well as for large population studies and screens for mutations causing rare diseases.

Besides the two HiSeq instruments, GATC is equipped with three Illumina GAs, two 454 GS FLX, and nine ABI 3730xl sequencers. The new HiSeq increases the firm's sequencing capacity to almost 20 terabases per year, the company said.

The Scan

Steps for Quick Review

The US Food and Drug Administration is preparing for the quick review of drugs and vaccines for the Omicron variant, according to the Wall Street Journal.

Moving Away From Using Term 'Race'

A new analysis finds that geneticists are using the term "race" in their papers less than in years past, as Science reports.

Point of the Program

The Guardian writes that some scientists have called the design of a UK newborn sequencing program into question.

Science Papers Present Multi-Omic Analysis of Lung Cells, Regulation of Cardiomyocyte Proliferation

In Science this week: a multi-omic analysis of lung cells focuses on RIT1-regulated pathways, and more.